REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/02/2026
Voltar para busca
Dado oficial do USPTO
AIDAR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
03/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42, 44
Data de depósito
15/07/2019
Data de registro
02/02/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/02/2021
Última transação
03/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
31/05/2019
Primeiro uso no comércio
03/07/2019
Código do desenho
4
Tipo de titular
16
Localização do titular
Pikesville, MD
Examinador
PAYABYAB, EDWARD TAN
Unidade examinadora
O10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Multisensor Diagnostics, LLC
Representantes
Andy I. Corea MURTHA CULLINA
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and management in the field of clinical careclinical research and clinical trialsclinical data and regulatory submission management on behalf of medicaldata analyticsbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business services provided to the healthcare industrythe collectionreportinganalysis of healthcare quality data and patient reported subjective and objective data for business purposes; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Services consisting of the registrationcollectiontranscriptioncompilation and systemization of written communications and data; Health care cost containment services; health care utilization management and review services; medical cost management
Classe 42
Disease management as a service (DMaaS) servicesproviding a website featuring technology for use by others to analyze disease progression prediction and for medical status assessment; Software as a service (SaaS) serviceshosting and managing software for use by others for use for overall health assessment; Data as a service (DaaS) services featuring software for use to determine effective drugstherapies and medications; Behavior Change as a service (BCaaS) services in the nature of software as a service (Saas) featuring software for facilitating behavior science backed coaching and training for use by others for behavior modification and healthy lifestyle modification; Platform as a service (PaaS) featuring computer software platforms for the collectionprocessingstorage and exchange of human health and disease data; Platform as a service (PaaS) featuring computer software platforms to derive insights and understanding about human health and disease; Platform as a service (PaaS) featuring computer software platforms for predictive analytics; Platform as a service (PAAS) featuring computer software platforms for disease progression prediction; Platform as a service (PAAS) featuring computer software platforms for medical status assessment and making medical decisions; Platform as a service (PaaS) featuring computer software platforms for determining effective therapies and medications; Platform as a service (PaaS) featuring computer software platforms for providing behavior therapy; providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research services in the fields of bloodbreathsaliva analysis and health care monitoring; breath and saliva biochemical analysis services; biological research; biomedical research; laboratory research in the field of biochemistrybiologyhealth and medicine; providing a web site featuring on-line non-downloadable software that enables patientsphysiciansinsurersbiopharmaceuticals and other healthcare providers to generateevaluatemanage and exchange medical information; Providing temporary use of on-line non-downloadable software and applications for communications between patientspayersbiopharmaceuticalscaregiverscontract research organizationshealth care providers in conducting health assessmentshealth coachingpreventative health measurescondition managementmaking informed health decisions; Providing temporary use of on-line non-downloadable software for collecting patient and care giver health information and facilitating communications between patientspayersbiopharmaceuticalscaregiverscontract research organizationshealth care providerspredictingrecordingreportingtransmittingtracking and monitoring patient real-time vital health information
Classe 44
Health care servicesproviding a database in the field of disease detectiontherapy and management information for treatment and diagnostic purposes; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Health care servicesbehavioral therapy for an individual or group of individuals for medical diagnosismanagementtreatment purposes; Providing wellness and disease management programs; behavioral health counseling servicesprograms in the field of behavioral change to promote wellness and disease management; mental health care counseling services; personal health assessmentspersonal assessments of health riskfitnessnutrition and lifestyle; providing smoking cessation and weight loss program services; managed health care servicesincludinghealth and wellness counseling services; disease care management services; nursing services; medical care home care servicesproviding personalized and customized health and wellness assessmenthealth caredisease managementmedical treatment and wellness plans and programs; medical care servicesproviding personalized and customized advice and recommendations on home health treatment and care programsproviding assistance in transitioning patients from hospital to homeevaluating and monitoring a patient's condition; providing on-line health care and health information relating to health coaching services; Medical evaluation servicesassessment of patients undergoing medical treatment; medical diagnostic monitoring services; medical monitoring servicesmonitoring the efficacy of therapy and total patient or consumer health; medical diagnostic testingmonitoring and reporting services; consulting services in the field of health; consulting services in the field of diagnostic medical testing; consulting services in the fields of health and healthcare; drug use testing services; maintaining patient medical records and files; medical counseling; medical screening; medical testing for diagnostic or treatment purposes; Dietitian services; Nutrition counseling; Dietary and nutritional guidance; Disease management as a service (DMaaS) servicesproviding medical analytics and healthcare services all for use by others for use for disease progression prediction and for medical status assessment
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
02/02/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
31/12/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30/12/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
13/11/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/11/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/10/2020
IUAF
USE AMENDMENT FILED
28/10/2020
EISU
TEAS STATEMENT OF USE RECEIVED
28/10/2020
EX1G
SOU EXTENSION 1 GRANTED
28/10/2020
EXT1
SOU EXTENSION 1 FILED
28/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
28/10/2020
DOCK
ASSIGNED TO EXAMINER
27/07/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/03/2020
PUBO
PUBLISHED FOR OPPOSITION
03/03/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/01/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
29/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
29/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/01/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
28/01/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/01/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
28/01/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/01/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/01/2020
GNFR
FINAL REFUSAL E-MAILED
21/01/2020
CNFR
FINAL REFUSAL WRITTEN
21/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/10/2019
GNRT
NON-FINAL ACTION E-MAILED
07/10/2019
CNRT
NON-FINAL ACTION WRITTEN
07/10/2019
DOCK
ASSIGNED TO EXAMINER
01/10/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/07/2019
NWAP
NEW APPLICATION ENTERED
18/07/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AIDAR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.